Delivering future health solutions.
Health & Life Sciences
#1 Biomanufacturing cluster in Europe
1st Life Sciences University Technical College in UK
#1 Research institution in the world for Tropical Medicine
One of largest concentrations of Cat 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
Latest Health & Life Sciences news
LIVERPOOL MEDICAL COMMUNITY UNITE TO RESEARCH COVID-19
CEIDR and HPRU EZI COVID-19 research programme The University of Liverpool (UoL), Liverpool School of Tropical Medicine (LSTM) and the NHS, represented by Liverpool Health Partners (LHP), have united to redirect the majority of Liverpool’s research efforts to COVID-19. Research programmes are designed to have immediate benefits for public health. This programme is supported by […]
UNIVERSTY OF LIVERPOOL JOINS SCIENTIFIC TEAM TO MAP SPREAD OF COVID-19
The Government and the UK’s Chief Scientific Adviser have today backed the UK’s leading clinicians and scientists, including a team from the University of Liverpool, to map how COVID-19 spreads and behaves by using whole genome sequencing. Through a £20 million investment, the consortium will look for breakthroughs that help the UK respond to this […]
NEW £1MILLION LIVERPOOL LAB TO HELP UNDERSTAND COVID-19
This includes £1m funding to establish and utilise the Outbreak Laboratory at Liverpool led by Professor Semple, Professor in Child Health and Outbreak Medicine, Consultant Respiratory Paediatrician at Alder Hey Children’s Hospital.
LIVERPOOL MEDICAL STUDENTS VOLUNTEER COVID-19 FRONTLINE
More than 230 final-year medical students at the University of Liverpool have volunteered to help the NHS tackle the COVID-19 crisis.
LIVERPOOL SEES 150% INCREASE FOR DIGITAL VC INVESTMENT IN TECH NATION’S LATEST REPORT
The results are in from this year’s Tech Nation report and there’s great news for Liverpool. The Tech Nation Report has been the UK’s state of the nation on tech since 2015. The report provides a look into the UK’s tech ecosystem, exploring the drivers of economic growth within the sector.
LIVERPOOL SCHOOL OF TROPICAL MEDICINE RESEARCHES WORK ON NEW COVID-19 DIAGNOSTIC
Researchers at Liverpool School of Tropical Medicine (LSTM) are working on diagnostic tests for COVID-19 that are suitable for implementation in low-middle income countries.
Matthews & Goodman appointed as sole agents at Liverpool Science Park
Matthews & Goodman has been appointed as sole letting agents at Liverpool Science Park (LSP).